C-Path

Filter by Category

Filter by Program

Filter by Date

November 16, 2017

FDA CDER Regulatory Science: The Importance of Partnership and Consortia

Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research within the United States Food and Drug Administration,

February 28, 2017

This webinar provides an overview of scientific, logistical, and regulatory considerations when using a BYOD approach to collect p

February 28, 2017

This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual i

February 24, 2017

Biomarker Qualification: Collaboration, Strategy, and Implementation Webinar February 24th, 2017 Presenter: John Michael Sauer, Ph

January 31, 2017

The CDISC Strategy Session highlight video includes an interview with Cheryl Fitzer-Attas (CHDI Foundation) discussing the importa

May 18, 2016

This webinar explores methodological approaches for determining whether changes observed in patient-reported outcome measures and

December 3, 2015

This webinar provides an overview of scientific and regulatory considerations when migrating paper-based patient-reported outcome

September 2, 2015

Evidentiary Considerations for Integration of Biomarkers in Drug Development Symposium On August 21st, the University of Maryland&

June 5, 2015

This webinar provides a detailed description of the process for conducting paper to ePRO migration, mode-specific migrations, usab

April 13, 2015

This webinar provides an overview of current ePRO data collection modes, the mode selection process, key considerations for select